Who owns POSEIDA THERAPEUTICS I COM?
- Ticker: PSTX
- CUSIP Number: 73730p108
Tip: Access positions for across all investors
Analyze quarterly positions in Poseida Therapeutics I with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Poseida Therapeutics I stock
Who bought or sold POSEIDA THERAPEUTICS I COM this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Pentwater Capital Management | 6.0M | $20M | 0% | Dec 2023 |
|
Vanguard Group | 2.9M | $9.7M | 10% | Dec 2023 |
|
Aisling Capital Management | 1.0M | $3.5M | 0% | Dec 2023 |
|
William Blair $ Company | 683k | $2.3M | -8% | Dec 2023 |
|
Millennium Management | 593k | $2.0M | -77% | Dec 2023 |
|
Charles Schwab Investment Management | 510k | $1.7M | 1% | Dec 2023 |
|
Dimensional Fund Advisors | 487k | $1.6M | 26% | Dec 2023 |
|
Goldman Sachs Group | 471k | $1.6M | 1% | Dec 2023 |
|
Jacobs Levy Equity Management | 438k | $1.5M | 100% | Dec 2023 |
|
Connor, Clark & Lunn Investment Management | 375k | $1.3M | 9% | Dec 2023 |
|
Point72 Asset Management | 335k | $1.1M | 235% | Dec 2023 |
|
MCF Advisors | 247k | $788k | 0% | Mar 2024 |
|
Bank of America Corporation | 238k | $798k | -31% | Dec 2023 |
|
Bank of New York Mellon | 230k | $773k | 9% | Dec 2023 |
|
Barclays | 121k | $408k | 166% | Dec 2023 |
|
HighTower Advisors | 120k | $402k | 0% | Dec 2023 |
|
Mirae Asset Global Investments | 114k | $383k | -56% | Dec 2023 |
|
DekaBank Deutsche Girozentrale | 100k | $342k | 0% | Dec 2023 |
|
Rhumbline Advisers | 89k | $300k | 2% | Dec 2023 |
|
CornerCap Investment Counsel | 80k | $267k | 0% | Dec 2023 |
|
Callan Capital | 77k | $257k | 0% | Dec 2023 |
|
UBS Group | 67k | $225k | 87% | Dec 2023 |
|
Cantor Fitzgerald, L. P. | 50k | $169k | 100% | Dec 2023 |
|
Hsbc Holdings | 49k | $161k | 0% | Dec 2023 |
|
Johnson Investment Counsel | 47k | $157k | 0% | Dec 2023 |
|
Jpmorgan Chase & Co | 46k | $155k | -27% | Dec 2023 |
|
Franklin Resources | 39k | $131k | 0% | Dec 2023 |
|
SG Americas Securities | 37k | $124k | 6% | Dec 2023 |
|
MetLife Investment Advisors | 36k | $122k | 0% | Dec 2023 |
|
American International | 34k | $114k | 0% | Dec 2023 |
|
Jane Street | 30k | $99k | 100% | Dec 2023 |
|
Palumbo Wealth Management | 26k | $83k | 100% | Mar 2024 |
|
AQR Capital Management | 24k | $79k | -73% | Dec 2023 |
|
Royal Bank of Canada | 23k | $79k | 84% | Dec 2023 |
|
New York State Common Retirement Fund | 23k | $76k | -44% | Dec 2023 |
|
Ohio Pers | 23k | $76k | 100% | Dec 2023 |
|
Wells Fargo & Company | 21k | $70k | 25% | Dec 2023 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 20k | $67k | 0% | Dec 2023 |
|
Alliancebernstein | 19k | $63k | 0% | Dec 2023 |
|
Florida State Board of Administration | 18k | $59k | 100% | Dec 2023 |
|
T. Rowe Price Associates | 17k | $56k | 20% | Dec 2023 |
|
Cubist Systematic Strategies | 17k | $55k | 20% | Dec 2023 |
|
Keystone Financial Group | 15k | $50k | 0% | Dec 2023 |
|
Creative Planning | 14k | $46k | 0% | Dec 2023 |
|
Mackenzie Financial | 14k | $45k | -15% | Dec 2023 |
|
Dynamic Technology Lab Private | 11k | $36k | 100% | Dec 2023 |
|
Citigroup | 9.8k | $33k | 774% | Dec 2023 |
|
FNY Investment Advisers | 8.3k | $27k | 10% | Dec 2023 |
|
Marcia E. Wade | 7.6k | $24k | 0% | Mar 2024 |
|
Lazard Asset Management | 7.5k | $0 | -76% | Dec 2023 |
|
Simplex Trading | 6.6k | $22k | 100% | Dec 2023 |
|
Legal & General Group | 6.1k | $21k | -6% | Dec 2023 |
|
Amalgamated Bank | 5.9k | $20k | -10% | Dec 2023 |
|
Summit Investment Advisors | 5.6k | $19k | 0% | Dec 2023 |
|
Point72 Middle East FZE | 5.3k | $18k | 100% | Dec 2023 |
|
Metropolitan Life Insurance Company | 3.8k | $13k | 0% | Dec 2023 |
|
Optimum Investment Advisors | 2.0k | $6.4k | 0% | Mar 2024 |
|
National Bank Of Canada /fi/ | 1.5k | $5.1k | 100% | Dec 2023 |
|
Voisard Asset Management Group | 270.00 | $862.002000 | 0% | Mar 2024 |
|
Farther Finance Advisors | 102.00 | $342.995400 | 100% | Dec 2023 |
|
Advisory Services Network | 80.00 | $269.000000 | -100% | Dec 2023 |
|
NISA Investment Advisors | 41.00 | $138.001900 | 100% | Dec 2023 |
|
Who sold out of Poseida Therapeutics I?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Squarepoint Ops | Sep 2023 | 222k | $529k |
Deutsche Bank Aktiengesellschaft | Sep 2023 | 36k | $85k |
Penserra Capital Management | Sep 2023 | 36k | $84k |
Citadel Advisors | Sep 2023 | 33k | $79k |
Winton Capital | Sep 2023 | 11k | $25k |
Two Sigma Securities | Sep 2023 | 10k | $24k |
Principal Financial Group | Sep 2023 | 10k | $24k |
China Universal Asset Management | Sep 2023 | 2.2k | $5.0k |
Daiwa Securities Group | Sep 2023 | 346.00 | $1.0k |